6892.TWO Taiwan Bio Therapeutics Co., Ltd
- Market cap
- TWD 2.29B
- P/E
- -
- P/B
- 2.90x
- ROE
- -52.3%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the fiscal year ending Dec 2025.
Is 6892.TWO undervalued?
Graham numberThe Graham number of Taiwan Bio Therapeutics Co., Ltd cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Taiwan Bio Therapeutics Co., Ltd fundamental analysis
No fundamental analysis for Taiwan Bio Therapeutics Co., Ltd yet.
Taiwan Bio Therapeutics Co., Ltd stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Taiwan Bio Therapeutics Co., Ltd
Taiwan Bio Therapeutics Co., Ltd., regenerative medicine company, focuses on the development of new cell medicines. It offers medicines for degenerative diseases, cardiovascular diseases, diabetes complications, and autoimmune diseases. The company was founded in 2014 and is based in Taipei, Taiwan.
Full company profileTaiwan Bio Therapeutics Co., Ltd financial statements
Taiwan Bio Therapeutics Co., Ltd annual financial statements (TWD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Income Statement | ||||||
| Revenue | - | 27.2M | 44.7M | 85.5M | 105M | 50.4M |
| Gross Profit | - | 22.6M | 31.7M | 76.4M | 56.1M | 32.1M |
| Operating Income | -34.9M | -87.3M | -183M | -212M | -351M | -384M |
| EBITDA | -32.3M | -58.4M | -129M | -146M | -247M | -249M |
| Net Income | -35.0M | -90.2M | -189M | -218M | -352M | -382M |
| EPS | -3.65 | -3.03 | -3.79 | -3.81 | -4.72 | -4.50 |
| Balance Sheet | ||||||
| Total Assets | 200M | 590M | 871M | 942M | 1.47B | 1.35B |
| Total Liabilities | 132M | 334M | 344M | 328M | 381M | 625M |
| Shareholders' Equity | 67.2M | 257M | 527M | 613M | 1.09B | 730M |
| Cash & Short-term Investments | 36.5M | 59.7M | 246M | 248M | 678M | 290M |
| Total Debt | 3.71M | 291M | 287M | 269M | 316M | - |
| Cash Flow | ||||||
| Operating Cash Flow | -30.4M | -59.2M | -140M | -167M | -252M | -212M |
| Capital Expenditure | 31.1M | 175M | 83.2M | 119M | 111M | 32.1M |
| Free Cash Flow | -61.5M | -234M | -223M | -286M | -363M | -244M |
| Ratios | ||||||
| ROE | -52.2% | -35.2% | -35.8% | -35.5% | -32.2% | -52.3% |
| ROA | -17.6% | -15.3% | -21.6% | -23.1% | -23.9% | -28.2% |
| Net Profit Margin | - | -332.1% | -421.4% | -254.5% | -334.7% | -756.8% |
| Debt to Equity | 0.06x | 1.14x | 0.54x | 0.44x | 0.29x | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Taiwan Bio Therapeutics Co., Ltd dividends
Taiwan Bio Therapeutics Co., Ltd has not paid dividends in the last 7 fiscal years.
Who owns Taiwan Bio Therapeutics Co., Ltd
Ownership data of Taiwan Bio Therapeutics Co., Ltd is not available yet.
Taiwan Bio Therapeutics Co., Ltd company profile
- Company name
- Taiwan Bio Therapeutics Co., Ltd
- Ticker
- 6892.TWO
- ISIN
- TW0006892003
- Exchange
- Taiwan OTC Exchange
- Sector
- Healthcare
- Industry
- Biotechnology
- Fiscal year end
- December
- Address
- 114, Lane 120, Taipei, Taiwan
- Phone
- 886 2 2695 6382
- Website
- twbio-thera.com
About Taiwan Bio Therapeutics Co., Ltd
Taiwan Bio Therapeutics Co., Ltd., regenerative medicine company, focuses on the development of new cell medicines. It offers medicines for degenerative diseases, cardiovascular diseases, diabetes complications, and autoimmune diseases. The company was founded in 2014 and is based in Taipei, Taiwan.